VTVT

Conviction 56HealthcareScan · Mon, Aug 10, 2026

VTVT$34.43-2.66%

ResistanceSupportVol 14

Vol MA14 122.6K

May 11May 28Jun 16Jul 6Jul 23Aug 10

vTv Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.vtvtherapeutics.com ↗

Price34.43

Change-2.66%

Gap-3.25%

Rel volume1.06×

Avg volume114.01K

Avg $ vol3.71M

SMA 2032.55

SMA 5033.35

SMA 20033.55

Price vs 50+3.24%

Price vs 200+2.64%

MA stackmixed

50/200 crossdeath · 3d

Supertrendup · 30.48

RSI (14)56

MACD hist0.43

MACD crossbull · 6d

Stoch %K / %D71 / 81

ADX (14)18

+DI / −DI21 / 11

RSI divergence—

MACD divergence—

ATR %+5.88%

ADR %5.76%

52w high42.72

52w low0.0000

From 52w high-19.40%

Above 52w low—

New 52w highNo

SqueezeOn · 9d

Bollinger width15.24%

%B0.88

Donchian pos70.58%

Donchian high36.51

Donchian low29.44

AVWAP (52w high)34.77

vs AVWAP high-0.96%

AVWAP (52w low)34.28

vs AVWAP low+0.42%

OBV trendUp

Chaikin MF (20)0.03

Today vs 20d1.06×

Avg vol (14d)122.6K

Avg vol (20d)114.01K

Avg $ vol (20d)3.71M

Market cap129.05M

RS 3m (vs SPY)+8.25%

RS 6m (vs SPY)-0.05%

RS line new highNo

Trend template5/8

Technical rank61.2

1 week+6.30%

1 month+2.81%

3 months+12.22%

6 months+18.64%

1 year+144.19%

YTD-13.06%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE-34.30%

ROA-30.79%

Debt/Eq0.03

Current12.48

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-46.11%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue0

Net income-13.05M

Gross profit—

Free cash flow-25.25M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out3.94M

Employees26

ListedThu, Jul 30, 2015

Free float1.59M

Float %40.4%

Short interest172.2K

Days to cover2.8d

Short volume59.1%

Squeeze score49 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction56 / 100

Pattern quality—

Tech rank61.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance38.58

Support29.74

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VTVT

All disclosures →

No recent disclosed trades by Congress in VTVT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VTVT · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Phillips Anne M. Director · Director stock option (right to buy) · 2026-06-26	Grant	6K	$210K	2026-06-26	2026-06-29
BAKER BROS. ADVISORS LP Director · Non-Qualified Stock Option (right to buy) · 2026-06-26	Grant	6K	—	2026-06-26	2026-06-29
AKKARAJU SRINIVAS Director · Director stock option (right to buy) · 2026-06-26	Grant	6K	$210K	2026-06-26	2026-06-29
Al-Marzooqi Fahed Director · Director stock option (right to buy) · 2026-06-26	Grant	6K	$210K	2026-06-26	2026-06-29
SPIEGELMAN DANIEL K Director · Director stock option (right to buy) · 2026-06-26	Grant	6K	$210K	2026-06-26	2026-06-29

SEC filings

EDGAR filings in VTVT · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.